hypertension - Articles and news items

waiver

FDA grants Kitov waiver for new drug application filing fee

Industry news / 6 April 2017 / Niamh Marriott, Junior Editor

The US Food and Drug Administration (FDA) has granted Kitov Pharmaceuticals a waiver related to the $2,038,100 new drug application filing fee for KIT-302…

Major global study reveals new hypertension and blood pressure genes

Industry news / 13 September 2016 / Niamh Louise Marriott, Digital Content Producer

The discoveries include DNA changes in three rare genes that have much larger effects on blood pressure in the population than previously seen, providing new insights into the physiology of hypertension and suggesting new targets for treatment…

FDA approves Allergan’s hypertension drug Byvalson

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Byvalson is the first and only fixed-dose combination (FDC) of a beta blocker (BB) and angiotensin II receptor blocker (ARB) available in the US…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+